Details for New Drug Application (NDA): 217087
✉ Email this page to a colleague
The generic ingredient in MINZOYA is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 217087
Tradename: | MINZOYA |
Applicant: | Lupin Ltd |
Ingredient: | ethinyl estradiol; levonorgestrel |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.02MG;0.1MG | ||||
Approval Date: | Feb 15, 2024 | TE: | AB3 | RLD: | No |
Complete Access Available with Subscription